Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/s41366-020-00677-2 http://scihub22266oqcxt.onion/10.1038/s41366-020-00677-2 32921796!7487073!32921796     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32921796&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Int+J+Obes+(Lond) 2020 ; 44 (12): 2479-2485 Nephropedia Template TP {{tp|p=32921796|t=2020. Obesity is a potential risk factor contributing to clinical manifestations of COVID-19 |pdf=|usr=}}{{32921796}} gab.com Text Obesity is a potential risk factor contributing to clinical manifestations of COVID-19 JO: Int J Obes (Lond) http://www.kidney.de/pget.php?&tw=1&pmid=32921796 #FOAvip BACKGROUND: Since December 2019, novel coronavirus (SARS-CoV-2)-induced pneumonia (COVID-19) occurred in Wuhan, and rapidly spread throughout China. COVID-19 patients demonstrated significantly different outcomes in clinic. We aimed to figure out whether obesity is a risk factor influencing the progression and prognosis of COVID-19. METHODS: 95 patients with COVID-19 were divided into obesity group and non-obesity group according to their body mass index (BMI). The demographic data, clinical characteristics, laboratory examination, and chest computed tomography (CT) were collected, analyzed and compared between two groups. RESULTS: Our data showed that COVID-19 patients with obesity had more underlying diseases and higher mortality rate compared to those without obesity. Furthermore, patients with obesity also demonstrated more severe pathological change in lung and higher blood lymphocytes, triglycerides, IL-6, CRP, cystatin C, alanine aminotransferase (ALT), erythrocyte sedimentation rate (ESR), which may greatly influence disease progression and poor prognosis of COVID-19. CONCLUSIONS: It suggest that obesity contributes to clinical manifestations and may influence the progression and prognosis of COVID-19 and it is considered as a potential risk factor of the prognosis of COVID-19. Special medical care and appropriate intervention should be performed in obesity patients with COVID-19 during hospitalization and later clinical follow-up, especially for those with additional other comorbidities. Twit Text FOAVip Obesity is a potential risk factor contributing to clinical manifestations of COVID-19 ????Int J Obes (Lond) http://www.kidney.de/pget.php?&tw=1&pmid=32921796 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32921796 #FOAvip English Wikipedia <ref>{{Cite pmid|32921796}}</ref> Obesity is a potential risk factor contributing to clinical manifestations of COVID-19 #MMPMID32921796 Kang Z; Luo S; Gui Y; Zhou H; Zhang Z; Tian C; Zhou Q; Wang Q; Hu Y; Fan H; Hu D Int J Obes (Lond) 2020[Dec]; 44 (12): 2479-2485 PMID32921796show ga BACKGROUND: Since December 2019, novel coronavirus (SARS-CoV-2)-induced pneumonia (COVID-19) occurred in Wuhan, and rapidly spread throughout China. COVID-19 patients demonstrated significantly different outcomes in clinic. We aimed to figure out whether obesity is a risk factor influencing the progression and prognosis of COVID-19. METHODS: 95 patients with COVID-19 were divided into obesity group and non-obesity group according to their body mass index (BMI). The demographic data, clinical characteristics, laboratory examination, and chest computed tomography (CT) were collected, analyzed and compared between two groups. RESULTS: Our data showed that COVID-19 patients with obesity had more underlying diseases and higher mortality rate compared to those without obesity. Furthermore, patients with obesity also demonstrated more severe pathological change in lung and higher blood lymphocytes, triglycerides, IL-6, CRP, cystatin C, alanine aminotransferase (ALT), erythrocyte sedimentation rate (ESR), which may greatly influence disease progression and poor prognosis of COVID-19. CONCLUSIONS: It suggest that obesity contributes to clinical manifestations and may influence the progression and prognosis of COVID-19 and it is considered as a potential risk factor of the prognosis of COVID-19. Special medical care and appropriate intervention should be performed in obesity patients with COVID-19 during hospitalization and later clinical follow-up, especially for those with additional other comorbidities. |COVID-19/blood/epidemiology/pathology/*physiopathology[MESH] |Cytokines/blood[MESH] |Humans[MESH] |Lung/diagnostic imaging/pathology[MESH] |Obesity/blood/epidemiology/physiopathology/*virology[MESH] |Pandemics[MESH] |Risk Factors[MESH] |SARS-CoV-2/isolation & purification[MESH]Obesity is a potential risk factor contributing to clinical manifestat(epmc).pdf DeepDyve Pubget Overpricing